Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Alzheimer’s diagnosis revamp embraces rating scale similar to cancer By Reuters
© Reuters. FILE PHOTO: Dr. Seth Gale points out evidence of Alzheimer?s disease on PET scans at the Center for Alzheimer Research and Treatment (CART)
Acumen’s Alzheimer’s drug passes initial safety test By Reuters
© Reuters. FILE PHOTO: Dr. Seth Gale points out evidence of Alzheimer’s disease on PET scans at the Center for Alzheimer Research and Treatment (CART)
Factbox-Companies in Alzheimer’s race after US nod for Eisai/Biogen drug By Reuters
© Reuters. FILE PHOTO: The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS/File
Biogen stock whipsaws despite FDA granting full approval for Alzheimer’s drug; analysts explain why By Investing.com
© Reuters. FDA converts Biogen and Eisai’s Alzheimer’s treatment to traditional approval The U.S. Food and Drug Administration (FDA) converted the approval status of Leqembi
US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug By Reuters
© Reuters. FILE PHOTO: The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS/File
Exclusive-US to build $300 million database to fuel Alzheimer’s research By Reuters
© Reuters. FILE PHOTO: Dr. Seth Gale points out evidence of Alzheimer’s disease on PET scans at the Center for Alzheimer Research and Treatment (CART)